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Prior genetic analysis suggests that there may exist an interaction between the products of the vaccinia virus genes A18R,
a putative negative transcription elongation factor, and G2R, a putative positive transcription elongation factor. In addition,
affinity purification of polyhistidine-tagged G2R protein overexpressed in vaccinia virus-infected cells, reported here, results
in copurification of the vaccinia H5R protein, previously characterized as a late viral transcription factor. We have therefore
used several methods to screen further for interactions among the G2R, A18R, and H5R proteins. Methods include
copurification or co-immunoprecipitation of proteins overexpressed during vaccinia virus infection, activation of the gal 4
promoter by gal 4 fusions in the yeast two-hybrid system, and co-immunoprecipitation of proteins synthesized in vitro in a
rabbit reticulocyte lysate. The results reveal interactions which include all possible pairwise combinations of the three
proteins G2R, A18R, and H5R; however, not all possible permutations of the interactions are observed and the interactions
are not observed in all environments tested. The results suggest that the vaccinia virus proteins G2R, A18R, and H5R interact
as part of a higher order transcription complex. © 1998 Academic Press
INTRODUCTION
Control of gene expression in prokaryotes, eu-
karyotes, and many viral systems is accomplished pri-
marily by the interaction of regulatory proteins with RNA
polymerase. Trans-acting factors that modulate initiation,
elongation, and termination of nascent RNA molecules
by both bacterial and eukaryotic RNA polymerases are
frequently associated with the core polymerase in a
large complex of proteins (Burgess et al., 1969; Mc-
Cracken et al., 1997; Uptain et al., 1997; Zawel and Re-
inberg, 1993). For example, several trans-acting factors
intimately associated with the yeast RNA polymerase II
have been identified using a combination of genetic and
biochemical studies. The genetic experiments uncov-
ered cold-sensitive extragenic suppressors of cells con-
taining a truncated form of the carboxy-terminal domain
(CTD) of the RNA polymerase II (Koleske and Young,
1995). Purification of the products of the suppressing
genes, known as SRB (suppressors of RNA polymerase
B), yielded a large RNA polymerase II-containing com-
plex which was stable throughout the initial purification
steps. Many of the proteins in the complex were subse-
quently identified as previously characterized GTFs (gen-
eral transcription factors) which are necessary for con-
trolled transcription initiation and elongation. Recent
evidence shows that the mammalian core RNA poly-
merase, several GTFs, and auxiliary kinases copurify on
an affinity column containing bound TFIIS, an RNA poly-
merase II elongation factor (McCracken et al., 1997).
Together these experiments suggest that the eukaryotic
RNA polymerase II functions in vivo as a high-order
complex in association with numerous initiation and
elongation factors.
Gene transcription during a vaccinia virus infection is
regulated predominately by the action of stage-specific
trans-activating factors (Moss, 1996). Viral early gene
expression takes place in the infecting virion particle,
and early transcripts are extruded into the host cyto-
plasm. The early genes encode protein factors respon-
sible for trans-activating intermediate gene expression,
the proteins encoded by intermediate genes trans-acti-
vate late viral genes, and late genes encode the early
transcription factors which are packaged into virions
along with RNA polymerase for the subsequent round of
infection. Intermediate and late transcription are both
coupled to viral DNA replication, and thus these gene
classes can be referred to collectively as ‘‘postreplica-
tive.’’ Highly purified in vitro systems are available for
study of early gene transcription initiation, elongation,
and termination (Baldick et al., 1994; Luo et al., 1991;
Hagler and Shuman, 1992; Deng and Shuman, 1996; Li
and Broyles, 1995). Relatively pure in vitro systems exist
for study of intermediate and late gene transcription
initiation (Kovacs and Moss, 1996; Passarelli et al., 1996;
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Hubbs and Wright, 1996; Rosales et al., 1994), but the
precise molecular function of the transacting factors re-
quired for expression of postreplicative genes is not fully
understood at the biochemical level.
Biochemical analysis of vaccinia early gene transcrip-
tion suggests that, as in the eukaryotic host, virus tran-
scription may be carried out by high-order RNA polymer-
ase complexes that are specific for each class of gene
expression. For example, purification of RNA polymerase
from vaccinia virions results in copurification of the
mRNA capping enzyme, early gene transcription termi-
nation activity, viral early transcription initiation factor
activity, and RAP94, a additional protein required for
initiation of early gene transcription (Ahn and Moss,
1992; Broyles and Moss, 1987; Deng and Shuman, 1996).
Analogous RNA polymerase complexes have not yet
been elucidated for transcription of the intermediate and
late classes of viral genes.
In vivo characterization of vaccinia viruses containing
mutations in the A18R and G2R genes suggests that the
proteins encoded by A18R and G2R are necessary for the
regulation of postreplicative viral transcription elongation
and/or termination and that they have complementary
activities (Black and Condit, 1996; Condit et al., 1996b;
Xiang et al., submitted for publication). A18R mutant vi-
ruses exhibit a phenotype termed ‘‘promiscuous tran-
scription,’’ defined as transcription of regions of the ge-
nome that are normally transcriptionally silent late during
infection (Bayliss and Condit, 1993). Recent experiments
suggest that promiscuous transcription results from
readthrough synthesis of longer-than-normal intermedi-
ate RNAs from upstream genes (Xiang et al., submitted
for publication). Thus the A18R protein may normally
serve as a negative regulator of transcription elongation
or possibly as a termination factor. Interestingly, treat-
ment of wt infections with the antipoxviral drug IBT pro-
duces the same phenotype as A18R mutant virus infec-
tions (Pacha and Condit, 1985; Bayliss and Condit, 1993).
Thus IBT seems to effect intermediate and late transcrip-
tion elongation by promoting readthrough transcription
or by inhibiting termination. Conversely, the G2R mutant
viruses synthesize abnormally short intermediate and
late viral RNAs which are trucated specifically at their 39
ends (Black and Condit, 1996). Treatment with IBT res-
cues growth of G2R mutant viruses (Meis and Condit,
1991), possibly by promoting elongation of the truncated
postreplicative mRNAs. Based on these observations we
hypothesize that the G2R protein functions as a positive
transcription elongation factor at postreplicative times of
a vaccinia infection.
Additional genetic data support the hypothesis that the
G2R and A18R proteins may interact either directly or
indirectly in a common pathway of regulation of postrep-
licative transcription. First, mutants in the G2R gene
serve as extragenic suppressors of mutations in the
A18R gene, suggesting at least a functional interaction
between the two proteins (Condit et al., 1996b). Second,
a mutation that confers resistance to IBT maps to the
second largest subunit of the RNA polymerase (Condit et
al., 1991). The action of IBT on a wt infection and the IBT
phenotype of the G2R and RNA polymerase mutant vi-
ruses suggests a functional interaction among G2R,
A18R, and RNA polymerase proteins.
The goal of this work was to explore the interactions
among several vaccinia proteins, including A18R and
G2R, that have been implicated in the regulation of pos-
treplicative viral transcription. We used several methods
to screen for protein–protein interactions both in vivo and
in vitro including copurification of proteins overex-
pressed in vaccinia virus, the yeast two-hybrid system
(Fields and Song, 1989), and co-immunoprecipitation of
specific viral proteins. The results reveal interactions
among A18R, G2R, and an additional late viral transcrip-
tion factor, H5R, and suggest that these proteins may
exist in a complex involved in the regulation of viral
postreplicative transcription elongation. Characterization
of these interactions may assist us in understanding the
role of the proteins in the regulation of transcription
elongation at postreplicative times of a viral infection.
RESULTS
Overexpression of hisG2R; monoclonal antibody
production
In order to obtain antigen for anti-G2R monoclonal
antibody production, we overexpressed an amino-termi-
nal polyhistidine-tagged G2R protein from a T7 promoter
in the vaccinia-T7 system. Purification of hisG2R, a 32-
kDa protein, resulted in copurification of a second pro-
tein of 44 kDa from the Ni21 affinity column (Fig. 1A). The
44-kDa protein was not seen in preparations of hisA18R
purified from infected cells by the same protocol (Fig.
1A), suggesting that the 44-kDa protein specifically inter-
acts with the hisG2R protein in vivo. The 44-kDa protein
was transferred from SDS–PAGE gels to PVDF mem-
brane following instructions from Ariad Pharmaceuticals,
Inc. and sent to Ariad for microsequencing. The N-termi-
nus of the protein was found to be blocked, but an
N-terminal sequence from two internal cyanogen bro-
mide fragments was obtained. The sequences obtained,
AEIRAHLKNS and VQVEAGKVNH, both match perfectly
with internal regions of the predicted translation product
of the H5R gene of vaccinia virus. The identity of the
44-kDa protein was confirmed by subsequent Western
blot analysis (Fig. 1B), which showed that the 44-kDa
protein reacts specifically with an antiserum raised
against the H5R protein. The H5R protein is a known
transactivator of late viral gene expression (Kovacs and
Moss, 1996). These data stimulated further experiments
to define protein–protein interactions among the G2R,
H5R, and A18R proteins.
We generated a monoclonal antibody using the
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hisG2R protein as antigen and screened the resulting
hybridomas by Western analysis against both the hisG2R
preparation and wt-infected cell extracts. In a Western
analysis, the resulting monoclonal antibody recognizes a
26-kDa protein in wt-infected cell extracts but not in
extracts of cells infected with the G2R mutant virus, G2A,
which contains a frameshifting deletion that truncates
the C-terminal two-thirds of the protein (Meis and Condit,
1991) (Fig. 2). Western blots also show that the monoclo-
nal antibody also recognizes hisG2R overexpressed dur-
ing a vvhisG2R infection. The antibody also immunopre-
cipitates radiolabeled hisG2R synthesized in vitro in a
rabbit reticulocyte lysate (data not shown). However, we
were unable to immunoprecipitate the in vivo synthe-
sized native 26-kDa G2R protein from wt infections or the
32-kDa hisG2R overexpressed from vvhisG2R infections.
Also, the monoclonal antibody specific for G2R does not
immunoprecipitate G2R or hisG2R from denatured in-
fected cell extracts. There are two possible explanations
for the failure of the monoclonal antibody to immunopre-
cipitate the G2R protein from infected cells. First, the
epitope recognized by the G2R monoclonal antibody may
be obscured in vivo, perhaps masked by other proteins,
but is available for binding in vitro. Second, the antigen–
antibody interaction may be of relatively low affinity and
therefore disrupted by the relatively stringent conditions
used for immunoprecipitation of proteins synthesized in
vivo but stable to the less stringent conditions used for
immunoprecipitation of proteins synthesized in vitro.
Because we were interested in exploring the interac-
tions among the proteins G2R, A18R, and H5R, we ana-
lyzed infected cell extracts by Western analysis using
antisera specific for each protein to determine the
steady-state levels of each protein. Initially, the G2R
monoclonal antibody was used in a Western blot analy-
sis of cell extracts infected with wt, G2A, vvhisG2R, and
vvhisA18R. Figure 2 shows that the native G2R protein is
visible in the wt extracts made at 6, 8, 10, 12, 16, and 24
hpi, but not in the G2A extract. The hisG2R protein,
slowed to an apparent molecular weight of 32 kDa due to
the amino-terminal polyhistidine tag, is visible in the
vvhisG2R lane. The blot was stripped and probed with a
monoclonal antibody specific for the A18R protein and
then stripped and probed with a polyclonal serum spe-
cific for the H5R protein. The G2R, A18R, and H5R pro-
teins are all found in wt-infected cells at late times of
infection. Western blot analysis of purified proteins (Fig.
1B) indicates that the anti-G2R, -H5R, and -A18R antibod-
FIG. 2. Western analysis of G2R, A18R, and H5R proteins in virus-
infected cells. Monolayers of BSC40 cells were infected with wt, G2A,
vvhisG2, or vvhisA18 viruses. Cell extracts were prepared from wt
infected cells at the times indicated above the lanes or from G2A-,
vvhisG2 1 vvTF7.3-, or vvhisA18 1 vvTF7.3-infected cells at 9 hpi. The
proteins were separated on SDS–PAGE and transferred to nitrocellu-
lose. The blots were probed with the G2R or A18R monoclonal anti-
bodies or an H5R polyclonal sera, as indicated at left. Only relevant
portions of the blots are shown.
FIG. 1. Electrophoretic and Western blot analysis of the hisG2R
protein preparation. Monolayers of BSC40 cells were infected with both
vTF7.3 and vvhisG2 or vvhisA18 (control) viruses at an m.o.i. of 10.
Cytoplasmic extracts were prepared and the his-tagged proteins were
purified by Ni21 affinity chromatography. The fractions were collected
from the column and the peak fractions were pooled and dialyzed. (A)
An aliquot of the hisG2R or hisA18R was analyzed by SDS–PAGE
followed by silver staining. The known proteins in each fraction are
identified on the right side of the figure. HisA18R* is an N-terminal
fragment of hisA18R resulting from premature termination by T7 RNA
polymerase (Bayliss and Condit, 1995). (B) A gel equivalent to (A) was
transferred to nitrocellulose and probed with anti-G2R (left), anti-H5R
(middle), and anti-A18R (right) antibodies. The same filter was used for
each Western, stripped between exposure to different primary antibod-
ies. Lanes labeled G are loaded with hisG2R protein; lanes labeled A
are loaded with hisA18R protein. The known proteins in each fraction
are identified on the right side of the figure.
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ies yield similar signals when reacted with equivalent
amounts of protein, and therefore the relative intracellu-
lar concentrations of G2R, H5R, and A18R can be approx-
imated by visual inspection of the blots in Fig. 2. Thus the
H5R protein is present in amounts equal to or slightly
greater than the A18R protein, while the G2R protein is
present in much lower amounts than either A18R or H5R.
We have used the antibodies specific for all three pro-
teins in subsequent experiments to further assay for
protein–protein interactions.
Protein–protein interactions in the two-hybrid system
The yeast two-hybrid system (Fields and Song, 1989)
was utilized to screen for interactions among the G2R,
H5R, and A18R proteins. Each of the viral genes was
cloned into both the DNA binding domain (GBN) and the
activation domain (GADN) vectors. The positive control
for the system was cotransformation of T antigen sub-
cloned in the activation domain construct and p53 sub-
cloned into the binding domain construct. Negative con-
trols include cotransformation of each construct with the
cognate vector lacking insert. A positive interaction in
both the filter assay and the liquid assay was seen when
the H5R gene was subcloned into the GADN vector and
cotransformed with the G2R gene subcloned into the
GBN vector (Table 1). However, when the H5R gene was
subcloned into the GBN vector and cotransformed with
the G2R gene subcloned in the GADN vector, no b-gal
activity was observed in either assay. Thus, the G2/H5
interaction was specific to the orientation of the viral
proteins in the fusion constructs. Additionally, the A18R
gene was subcloned into both the GBN and GADN vec-
tors and cotransformed in all combinations with both the
G2R and H5R constructs. None of these cotransforma-
tions resulted in b-gal activity by filter or liquid assay
(data not shown).
The data gathered from the two-hybrid screen is con-
sistent with the interaction between H5R and G2R ob-
served when G2R is overexpressed by a recombinant
vaccinia virus. Nevertheless, we chose to explore the
hypothesized protein–protein interactions further by al-
ternative approaches.
In vivo co-immunoprecipitations
We have used co-immunoprecipitation experiments to
test for interactions among the G2R, A18R, and H5R
proteins in vivo (Fig. 3). Cells were infected with wt, G2A,
vvhisG2R, vvhisA18R, or a mixture of vvhisG2R and
vvhisA18R viruses. The infected cells were harvested at
3 or 9 h postinfection and lysates were immunoprecipi-
tated with antisera specific for the G2R, A18R, or H5R
proteins. The immune complexes were separated on
SDS–PAGE and transferred to nitrocellulose for Western
analysis. The Western blots were probed with various
antibodies to determine co-immunoprecipitating pro-
teins. The Western analyses were controlled by the use
of total cytoplasmic extracts from wt- and G2A-infected
cells electrophoresed alongside the immunoprecipitated
proteins. Background immunopositive proteins of ap-
proximately 25 and 50–60 kDa seen in the mock lanes in
the Western analyses are immunoglobulin chains from
the initial immunoprecipitation that react with secondary
antibody in the Western blot. Nonspecific co-immunopre-
cipitating proteins were controlled for by the use of a
monoclonal antibody specific for a yeast protein in the
initial immunopreicpitation followed by Western analysis
with antisera specific for the candidate proteins G2R,
A18R, and H5R.
Initially, infected cell extracts were immunoprecipi-
tated with the A18R monoclonal antibody (Fig. 3, top two
panels). The 56-kDa native A18R and the 57-kDa hisA18R
proteins can be precipitated with the A18R antibody from
infected cell extracts but not mock-infected cell extracts,
as confirmed by both radioimmunoprecipitation and by
Western analysis of immunoprecipitated proteins with
the A18R monoclonal antibody (data not shown). The
proteins immunoprecipitated by the A18R monoclonal
antibody were analyzed by Western blots using either the
G2R monoclonal antibody (Fig. 3, top left) or the H5R
polyclonal serum (Fig. 3, top right). Western analysis with
the G2R antibody reveals a 32-kDa band corresponding
to the hisG2R protein in infections with vvhisG2R (lane 6).
This same 32-kDa hisG2R band is present in abundance
in immunoprecipitates from cells infected with both
vvhisG2R and vvhisA18R (lane 8). It is noteworthy that
more hisG2R is present in immunoprecipitates from
mixed infections with both vvhisG2R and vvhisA18R than
is present in immunoprecipitates from cells infected with
vvhisG2R alone. This observation indicates that the
quantity of G2R protein co-immunoprecipitated is propor-
tional to the amount of A18R present in extracts. A very
small amount of native G2R protein, which runs at 26 kDa
(lane 10), was reproducibly observed in immunoprecipi-
tates from cells in which A18R was overexpressed (lanes
TABLE 1




domain hybrid Colony colora b-Gal activityb
GBN GADN 2 nd
GBNG2R GADN 2 1.3
GBNG2R GADNH5R 1 96.4
GBNH5 GADNG2R 2 0.0
GBN GADNH5R 2 1.1
GBNH5 GADN 2 nd
p53 T antigen 11 1441.2
Note. nd, not done.
a (2) white, (1) light blue, (11) deep blue.
b b-Gal activity expressed in nmol/mg protein/min.
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7 and 8). The proteins immunoprecipitated by the A18R
monoclonal antibody did not include the H5R protein
(Fig. 3, top right) although the control cell extracts dem-
onstrated that H5R was recognized in a Western analysis
(lanes 10 and 11). In summary, these data show that
immunoprecipitation of the A18R protein from infected
cell extracts results in co-immunoprecipitation of G2R,
and that H5R does not co-immunoprecipitate with A18R.
Incubation of infected cell extracts with H5R polyclonal
serum immunoprecipitates the 44-kDa H5R protein in wt,
G2A, vvhisG2R, vvhisA18R, and mixed infections but not
mock-infected cell extracts as determined by both radio-
immunoprecipitation and by Western analysis of immu-
noprecipitated proteins (data not shown). Western anal-
ysis of proteins immunoprecipitated with the H5R poly-
clonal serum done with either the G2R (Fig. 3, middle left)
or A18R (Fig. 3, middle right) monoclonal antibody shows
that hisG2R and hisA18R are included in the immunopre-
cipitated proteins, respectively. Native G2R protein is
undetectable in the Western analysis of proteins immu-
noprecipitated by the H5R antibody, although the G2R
protein is present in the control extracts (lane 10). Inter-
estingly, overexpression of both hisA18R and hisG2R
results in increased co-immunoprecipitation of hisG2R
relative to overexpression of hisG2R alone (compare
lanes 8 and 6, middle left panel). This suggests that at
least a portion of the hisG2R protein exists as part of a
higher order complex which also contains A18R and that
overexpression of hisA18R increases the amount of this
complex and thus the amount of immunoprecipitated
FIG. 3. Co-immunoprecipitation analysis of viral proteins synthesized in vivo. Monolayers of BSC40 cells were infected with wt, G2A, vvhisG2, or
vvhisA18 or coinfected with vvhisG2 plus vvhisA18. Cells infected with recombinant viruses expressing polyhistidine-tagged proteins were also
co-infected with vvTF7.3. The cells were harvested into RIPA buffer at 3 or 9 h postinfection and treated with benzonase. The insoluble material was
pelleted by centrifugation and the cleared lysate was immunoprecipitated with A18R monoclonal antibody, H5R polyclonal sera, or a monoclonal
antibody specific for a yeast protein. The immunoprecipitated proteins were separated on SDS–PAGE and transferred to nitrocellulose for Western
analysis. The antibodies used for the immunoprecipitation (IP) or Western (W) analysis are indicated at the bottom of each panel. For each panel: lane
1, mock-infected extract; lane 2, wt infection, 3 hpi; lane 3, wt infection, 9 hpi; lane 4, G2A infection, 3 hpi; lane 5, G2A infection, 9 hpi; lane 6, vvhisG2
infection, 9 hpi; lane 7, vvhisA18 infection, 9 hpi; lane 8, vvhisG2 1 vvhisA18 infection, 9 hpi; lane 9, blank; lane 10, wt total cytoplasmic extract, not
immunoprecipitated; lane 11, G2A total cytoplasmic extract, not immunoprecipitated. Molecular weight markers are shown on the left side of the
panels.
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hisG2R. Unfortunately, hisA18R (lanes 7 and 8, middle
right panel) coelectrophoreses with the background of
rabbit Ig heavy chain; however, the 57-kDa signal in
these vvhisA18R immunoprecipitates is reproducibly sig-
nificantly greater than the background. It is unclear
whether native A18R is included in the proteins immu-
noprecipitated by the H5R antisera, although it is present
in the control extracts (lanes 10 and 11). In summary,
these data show that immunoprecipitation of H5R results
in co-immunoprecipitation of both hisG2R and hisA18R.
A monoclonal antibody specific for a yeast protein was
used as a control to test for nonspecific co-immunopre-
cipitation of G2R and A18R (Fig. 3, bottom panels). West-
ern analysis of the proteins immunoprecipitated with the
yeast monoclonal antibody reveal neither G2R nor
hisG2R, A18R, or hisA18R (lanes 1–8), though G2R and
A18R are recognized in the control extracts (lanes 10 and
11). We conclude based on this control that the co-
immunoprecipitating proteins observed in the previous
experiments are not nonspecifically precipitated by the
monoclonal antibodies.
As noted above, we are unable to immunoprecipitate
the G2R protein from either wt or vvhisG2R recombinant
virus-infected cell extracts. Therefore, we did not under-
take the task of Western analyses of G2R immunopre-
cipitates with the A18R or H5R antisera.
In vitro co-immunoprecipitations
While the in vivo immunoprecipitations suggest that
interactions involving G2R, A18R, and H5R occur in vivo,
we wanted to further analyze the protein–protein inter-
actions in the absence of other viral proteins. To accom-
plish this, we synthesized hisG2R, hisA18R, or H5R indi-
vidually, in pairs, or in triplicate in vitro and immunopre-
cipitated with the individual antibodies. We found that
while the G2R, A18R, and H5R antibodies each immuno-
precipitated their cognate protein in vitro, in no case did
we observe co-immunoprecipitating proteins (data not
shown).
GST-G2 bead binding
We tested the hypothesis that G2R interacts with
H5R and A18R in vivo in a GST-G2 cobinding experi-
ment (Fig. 4). A549 cells were infected with a vaccinia
virus expressing the T7 RNA polymerase (vTF7.3) and
transfected with pTM1GST-G2, a plasmid DNA encod-
ing a GST-G2 fusion protein driven by a T7 promoter.
The vTF7.3 infection provides wt vaccinia proteins in
addition to supplying T7 RNA polymerase for expres-
sion of the GST-tagged proteins. A control experiment
was done by infecting A549 cells with vTF7.3 and
transfecting pTM1GST-Sendai P, a plasmid DNA con-
taining a fusion of GST with the Sendai virus P protein
driven by a T7 promoter. The GST-G2 or GST-P pro-
teins were overexpressed in the infected cells and
purified from lysolecithin extracts of the infected/trans-
fected cells using the glutathione–Sepharose beads
as described under Materials and Methods. Figure 4A
shows the total radiolabeled proteins which cobind
GST-G2 or GST-Sendai P from infected/transfected cell
extracts. GST-G2 migrates at approximately 60 kDa
and GST-P migrates at approximately 100 kD. No co-
binding proteins were detected using this assay. Fig-
ure 4B shows a Western analysis of total infected/
transfected cell extract and glutathione–Sepharose
bead-bound protein analyzed with both the G2R mono-
clonal antibody and the Sendai P monoclonal antibody
FIG. 4. Cobinding of H5R with GST-G2. Monolayers of A549 cells
were infected with vTF7.3 at 37°C and transfected with pTM1GST-G2
(gst-G2) or pTM1GST-Sendai P (gst-P) DNA. The infected/transfected
cells were labeled with Trans[35S]methionine for 16–18 h. Following the
labeling period, cytoplasmic extracts were made using lysolecithin
permeabilization. (A) The extracts were incubated with glutathione–
Sepharose 4B and the bead-bound proteins were solubilized, analyzed
on SDS–PAGE, dried, and exposed to film. (B and C) The bead-bound
proteins were analyzed on SDS–PAGE, transferred to nitrocellulose,
and probed in a Western analysis with a mix of monoclonal antibodies
specific for G2 and Sendai P (B) or polyclonal sera specific for H5R (C).
For (B) and (C), the Western analyses were done using both total extract
and bead-bound protein as indicated. For (A–C), both mock transfec-
tions and transfections at two concentrations of plasmid DNA were
done as indicated in the figure. The relative mobilities of the proteins of
interest are shown at the right of each panel.
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in the same reaction. Western analysis fails to show
the native G2R protein at approximately 26 kDa in an
infected but mock-transfected extract, probably be-
cause lesser amounts of cell extract are analyzed in
these experiments than in the control Western blots in
Fig. 3. GST-G2 is immunoreactive with the G2R anti-
body and the Sendai P monoclonal antibody detects
GST-P. The Western blots in Fig. 4B were stripped and
reprobed with the H5R polyclonal sera (Fig. 4C). The
vaccinia protein H5R cobinds GST-G2 protein on glu-
tathione–Sepharose beads as detected by Western
analysis. There is some H5R cobinding GST-P but an
increased quantity reproducibly cobinds GST-G2. The
blot was stripped of the secondary horseradish per-
oxidase antibody and reprobed with the monoclonal
antibody specific for the A18R protein. A18R cobinds
neither GST-P nor GST-G2 (data not shown). In sum-
mary, these experiments provide further evidence for
an interaction between the vaccinia proteins H5R and
G2R expressed in vivo.
DISCUSSION
We have obtained biochemical evidence suggesting
that the vaccinia virus proteins G2R, A18R, and H5R
interact as part of a higher order transcription complex.
In general, the experimental approach is to use one
protein as a ‘‘bait,’’ namely, conjugated to the yeast gal4
DNA binding domain, a histidine or GST tag, or specifi-
cally immobilized on protein A with an antibody, then
present the bait to a selection of other proteins, and
determine what if any proteins are captured. We have
tested for interactions in several different environments,
including synthesis in vaccinia virus-infected cells, in
yeast, or in vitro. Figure 5 provides a diagrammatic sum-
mary of the interactions we have observed. The results
(Fig. 5) reveal interactions which include all possible
pairwise combinations of the three proteins, G2R, A18R,
or H5R; however, not all possible permutations of the
interactions are observed and the interactions are not
observed in all environments tested. For example, we
have found evidence for an interaction between A18R
and H5R; however, the interactions are seen only via
immunoprecipitation from virus-infected cells and not in
yeast or in vitro, and the interactions are unidirectional,
that is, A18R coprecipitates in an anti-H5R antibody-
mediated immunoprecipitation, while H5R does not co-
precipitate in an anti-A18R antibody-mediated immuno-
precipitation.
The conditions under which we detect protein–protein
interaction may provide information about the nature of
the interaction, specifically whether it represents a direct
physical contact between two proteins or an association
mediated by another macromolecule. Two experiments
strongly suggest that the interaction between the G2R
and H5R proteins represents a direct interaction. First,
purification of an amino-terminal histidine-tagged G2R
protein synthesized in vivo using the vaccinia-T7 overex-
pression system results in copurification of H5R in the
absence of any other detectable proteins or nucleic ac-
ids. Second, the GBNG2R–GADNH5R interaction ob-
served in the yeast two-hybrid system most likely repre-
sents a direct interaction, since no other vaccinia pro-
teins are present and the interaction is unlikely to be
mediated by another yeast protein. By contrast, all of the
other interactions, namely, A18R with H5R and G2R with
A18R, are observed only via immunoprecipitation from
vaccinia virus-infected cells and not in yeast or in vitro.
While such negative results must be interpreted with
extreme caution, it is nevertheless tempting to speculate
that these latter interactions may be mediated by addi-
tional macromolecules (protein, DNA, or RNA) found only
in vaccinia virus-infected cells. A logical and provacative
candidate for a mediating macromolecule would be the
viral RNA polymerase.
Based on prior genetic experiments (see Introduc-
tion) and on the results reported here, we envision
postreplicative vaccinia transcription elongation to be
regulated by a dynamic complex of proteins which
includes at least H5R, G2R, and A18R and which may
interact directly with the viral RNA polymerase. The
interaction between G2R, a putative positive transcrip-
tion elongation factor, and A18R, a putative negative
transcription elongation factor, was predicted based
on genetic experiments revealing both complementary
transcription elongation phenotypes and genetic sup-
pression (Black and Condit, 1996; Condit et al., 1996b).
The discovery of an interaction between these pro-
teins and H5R, a viral late transcription factor (Kovacs
and Moss, 1996), lends support to the notion that A18R
and G2R may function in a higher order complex con-
taining additional transcription factors. Hopefully, fur-
ther genetic and biochemical characterization of the
vaccinia virus transcription elongation factors will pro-
FIG. 5. Diagrammatic representation of the protein interaction
data. The three viral proteins of interest (G2R, A18R, and H5R) are
shown at the corners of the triangle. Interactions between the
proteins were assayed by using one protein as ‘‘bait’’ and testing for
the capture of the other proteins. In the diagram, the ‘‘bait’’ is found
at the tail of the arrow and the ‘‘captured’’ protein is found at the head
of the arrow. The assay(s) utilized is found immediately adjacent to
the relevant arrow.
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vide additional insights into transcription elongation
and its relation to both initiation and termination.
MATERIALS AND METHODS
Cells, viruses, bacterial hosts, and antibodies
A549, BSC40, and Rat2 cells, vaccinia virus wild-type
strain WR, the G2R deletion mutant G2A, the recombi-
nant vaccinia virus vTF7.3 (Fuerst et al., 1986), which
expresses the bacteriophage T7 RNA polymerase, and
the conditions for their growth, infection, and plaque
titration have been described previously (Condit and
Motyczka, 1981; Condit et al., 1983, 1996a; Meis and
Condit, 1991; Bayliss and Condit, 1993). IBT was pre-
pared as described previously (Pacha and Condit, 1985)
and used at a final concentration of 45 mM.
The vaccinia recombinant vvhisG2R was constructed
by transfecting wild-type virus-infected cells with the
plasmid pTM1-G2R (see below) and selecting for thymi-
dine kinase-negative recombinants on Rat2 cells (Aus-
ubel et al., 1987). The resulting recombinant virus con-
tains a amino-terminal polyhistidine–G2R fusion, driven
by a T7 RNA polymerase promoter, located in the vac-
cinia virus thymidine kinase gene. The structure of the
recombinant was confirmed by PCR analysis using ap-
propriate primers specific for the G2R ORF.
Monoclonal antibodies were prepared by the Univer-
sity of Florida Interdisciplinary Center for Biotechnology
Research (ICBR) hybridoma laboratory using histidine
tagged A18R and G2R (see below) proteins purified by
nickel column affinity chromatogrpahy as antigens. The
polyclonal serum specific for the H5R protein was kindly
provided by Dr. Paula Traktman (Cornell University). The
yeast monoclonal antibody was kindly provided by Dr.
Maurice Swanson (University of Florida).
Plasmid constructs
pET16bG2R contains the vaccinia virus G2R coding
sequence inserted in frame downstream from an amino-
terminal polyhistidine tag in the vector pET16b (Nova-
gen). The G2R coding sequence was subcloned from the
plasmid pgG2rap (Condit et al., 1996b). pgG2rap was
digested with NdeI and BamHI. The NdeI site at the 59
end includes the authentic translation initiation codon of
G2R. The NdeI, BamHI fragment was subcloned into
cleaved pET16b generating pET16bG2R.
The plasmid construct pTM1his-G2 contains the poly-
histidine–G2R fusion driven by a T7 RNA polymerase
promoter flanked by the 59 and 39 terminal segments of
the vaccinia virus thymidine kinase gene. pTM1his-G2
was constructed by cloning the NcoI, BamHI fragment
from pET16bG2R, which contains the polyhistidine–G2
fusion, into pTMI cleaved with NcoI and BamHI (Ausubel
et al., 1987).
pGEMH5 was constructed to contain the vaccinia
virus H5R coding sequence inserted in the multiple
cloning site of pGEM3Zf-. The H5R coding sequence
was initially PCR amplified from vaccinia virus WR
DNA using primers that inserted a EcoRI site at the 59
end and a BamHI site at the 39 end. The EcoRI, BamHI-
cleaved PCR product was cloned into EcoRI, BamHI-
cleaved pGEM3Zf- generating pGEMH5. The cloned
H5R gene was sequenced to confirm the fidelity of the
PCR reaction.
pGADN-H5 and pGBN-H5 were constructed by PCR
amplification of the H5R ORF from vaccinia virus WR
DNA using primers that inserted an NdeI site at the 59
end and a BamHI site at the 39 end of the H5R gene.
To create pGADN-H5, the PCR product was cleaved
with NdeI and BamHI and cloned into the NdeI,
BamHI-cleaved pGADN vector. The cloned H5R gene
was sequenced to confirm the fidelity of the PCR
reaction. pGBN-H5 was constructed by subcloning the
H5 ORF-containing NdeI, BamHI fragment from
pGADN-H5 into NdeI, BamHI-cleaved pGBN. The
pGADN and pGBN vectors (a gift from P. Traktman,
Cornell University) are modifications of the pGAD24
and pGBT9 plasmids (Clonetech), respectively, in
which the EcoRI site in each vector was removed and
replaced with an NdeI site. pGADN-G2 and pGBN-G2
were constructed by subcloning the G2R ORF from
pgG2Rap, generated by cleaving the plasmid DNA
with NdeI and BamHI, into the vectors pGADN and
pGBN cleaved with NdeI and BamHI.
pTM1GST-G2 contains the vaccinia virus G2R open
reading frame inserted in frame downstream from the
GST cassette. The pTM1GST vector contains the GST
gene inserted into pTM1 multiple cloning site (Chandrika
et al., 1995; Stein et al., 1989) (Merchilinsky, unpublished
data). The G2R open reading frame was subcloned into
pTM1GST from pgG2rap by PCR amplification of the G2R
open reading frame which generated a BamHI site at the
59 end of the open reading frame and a PstI site at the 39
end. The BamHI, PstI-cleaved PCR product was ligated
into the BamHI, PstI-digested pTM1GST vector generat-
ing pTM1GST-G2. The insert was sequenced to verify the
fidelity of the PCR reaction.
Overexpression and purification of hisG2R protein
The amino-terminal polyhistidine–G2R fusion pro-
tein (hisG2R) was purified from BSC40 cells coinfected
with recombinant viruses vTF7.3 and vvhisG2R as de-
scribed previously (Simpson and Condit, 1995; Bayliss
and Condit, 1995). Cytoplasmic extracts of the virus-
infected cells were prepared and applied to the His-
Bind column (Novagen). The hisG2R protein was
eluted from the column with increasing concentrations
of imidazole. Peak fractions were identified by Brad-
ford protein assay (Bio-Rad), pooled, and dialyzed
against 20 mM Tris–HCl, pH 8.0, 40 mM KCl, and 40%
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glycerol over a period of 24 h. The protein was stored
at 220°C.
Two-hybrid screen
Transformations of Saccharomyces cerevisae, Y190
strain (Clonetech), were done with combinations of the
GBN and GADN constructs using the LiOAc/PEG method
as described (Rose et al., 1990). The b-galactosidase
filter assays were done as previously described in the
Matchmaker Library protocol (Clonetech). The b-galac-
tosidase liquid assays were done as previously de-
scribed (Rose et al., 1990).
In vivo immunoprecipitation and Western blot analysis
Confluent monolayers of BSC40 cells in 35-mm dishes
were infected with vaccinia virus at an m.o.i. of 30 or
mock-infected. Cells were harvested in RIPA lysis buffer
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.1%
SDS, 1 mg/ml aprotinin (Sigma)). The lysates were frozen
and thawed, treated with 100U/ml benzonase (Sigma) for
30 min at 37°C, and then clarified by centrifugation for 10
min at 15,000 rpm in a microfuge at 4°C. Clarified lysates
were incubated with antiserum for 2 h at 4°C with rota-
tion. Following monoclonal antibody incubation, a sec-
ondary antibody specific for mouse Ig was added to the
lysates at 4°C with rotation. Protein A–Sepharose was
added for 30 min at 4°C. The immune complexes were
harvested by centrifugation and washed three times with
RIPA lysis buffer. Samples were resuspended in SDS
loading buffer, boiled, and analyzed by SDS–PAGE using
10% separating gels. The proteins were transferred to
nitrocellulose in 25 mM Tris–HCl, 192 mM glycine, 20%
methanol at 4°C overnight. Nitrocellulose filters were
incubated with primary antibody, and the bound antibody
was detected using polyclonal anti-mouse or anti-rabbit
horseradish peroxidase-conjugated antibody (1:5000;
Amersham) and enhanced chemiluminescence. Western
blotting reagents (Amersham) were used as described
by the manufacturer.
Coupled in vitro transcription/translation
The G2R, A18R, and H5R proteins were made in vitro
using the TnT Quick coupled reticulocyte lysate system
(Promega) as described. Briefly, pET16bG2R (expresses
hisG2R), pTM1GST-G2 (expresses GST-G2), pET16bA18R
(expresses hisA18R) (Simpson and Condit, 1995; Bayliss
and Condit, 1995), and pGEMH5 (expresses native H5),
each driven by a T7 promoter, were used to program the
in vitro transcription/translation reaction. Supercoiled
plasmid DNA was added at 0.5-1.0 mg per 12.5-ml reac-
tion and the reaction was incubated with 10 ml TnT Quick
Lysate (Promega), 5 mCi Redivue Pro-Mix [35S] (Amer-
sham) and incubated for 2 h at 30°C. The resulting
proteins were immunoprecipitated in NP-40 buffer (0.25%
NP-40, 150 mM NaCl, 50 mM Tris–HCl (pH 7.5)) and
analyzed by SDS–PAGE using a 10% separating gel,
fluorographed, dried, and autoradiographed.
Affinity purification of GST-G2 and interacting
proteins
GST-G2 or GST-P (kindly provided by Dr. Sue Moyer,
University of Florida), GST fusion proteins driven by a T7
promoter, was synthesized by transfection into vTF7.3-
infected A549 cells. Confluent monolayers of A549 cells
were infected with vTF7.3 at an m.o.i. of 10. The cells
were incubated at 37°C for 4 h in DME and 10% Hyclone.
The cells were washed in DME and transfected with 0,
2.5, or 5 mg of pTM1GST-G2 or pTM1GST-P in DME. The
cells were labeled with 100 mCi of Tran[35S]label (ICN
Biochemical, Irvine, CA) for 16–18 h in DME and 2%
Hyclone. Lysolethicin extracts of the infected/transfected
cells were made as for in vitro transcription as described
(Condit et al., 1996a). For both the in vitro and in vivo
synthesized GST-G2, purification on glutathione–Sepha-
rose 4B was done using the same technique. Specifi-
cally, an aliquot of glutathione–Sepharose beads was
washed in transcription wash solution [25 mM Hepes
(pH 7.4), 50 mM potassium acetate] and then incubated
in transcription wash solution containing 0.1% NP-40,
0.5% dry milk, and 1% BSA on ice for 15 min. The beads
were washed again in transcription wash solution con-
taining 0.1% NP-40. An aliquot of beads in 50 ml of
transcription wash solution containing 0.1% NP-40 was
added to either in vitro synthesized protein in 350 ml
transcription wash solution containing 0.1% NP-40 or 100
ml cell extract in 250 ml transcription wash solution con-
taining 0.1% NP-40. The proteins were allowed to bind
beads for 15 min on ice. The bead-bound protein was
washed three times in transcription wash solution con-
taining 0.1% NP-40, and the bound protein was solubi-
lized in SDS loading buffer. The solubilized protein was
separated on 10% SDS–PAGE, fluorographed, and auto-
radiographed or transferred to nitrocellulose and probed
in a Western analysis.
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